The focus of this year’s conference is to connect the global synthetic biology community by fostering the participation and dialogue between entrepreneurs, business executives, tech practitioners, technology scouts, academics, investors, and other great minds driving the latest commercial developments in the industry. At SynBioBeta London 2016, you’ll meet attendees from around the globe, learn best practices, and hear from over 40 industry thought leaders, including the recently announced keynote, Tom Knight, Co-Founder of Boston-based company Ginkgo Bioworks, as he discusses what he sees in store for the future of the industry.

Join us for conversations, panels, talks, and fireside chats on industry-specific progress covering topics that will include:  synthetic biology for biopharmaceuticals and healthcare, engineering the microbiome, next generation applications and responsible innovation around Clinical use of CRISPR in the UK. SynBioBeta London 2016 is a must attend event for those wanting to connect and keep up to date with the rapidly-evolving synthetic biology industry.

“As the industry continues to grow and strengthen, I’m excited to see so many new European synthetic biology focused startups presenting for the first time at SynBioBeta London this year” said John Cumbers, Founder of SynBioBeta. “We look forward to learning about their new applications and technology, and understanding how they are making biology easier to engineer.”